6.59
+0.03(+0.46%)
Currency In USD
Address
645 Summer Street
Boston, MA 02210
United States of America
Phone
857 254 1500
Website
Sector
Healthcare
Industry
Medical - Devices
Employees
246
First IPO Date
December 18, 2020
| Name | Title | Pay | Year Born |
| Dr. Kevin J. Knopp Ph.D. | Co-Founder, Chief Executive Officer, President & Director | 993,288 | 1973 |
| Mr. Michael S. Turner Esq., J.D. | Chief Legal & Administrative Officer and Secretary | 470,646 | 1967 |
| Dr. Christopher David Brown Ph.D. | Co-Founder, Board Advisor & Director | 555,607 | 1975 |
| Mr. Joseph H. Griffith IV | Chief Financial Officer & Treasurer | 576,022 | 1975 |
| Ms. Barbara Russo | Vice President of Marketing & Corporate Communications | 0 | 1963 |
| Mr. Don Osmer | Vice President of Human Resources | 0 | 1966 |
908 Devices Inc., a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry (Mass Spec) devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, industrial biotech, forensics, and adjacent markets. The company's products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of gas, liquid, and solid materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the extracellular environment in bioprocesses; and ZipChip solution, a plug-and-play, high-resolution separation platform that optimizes Mass Spec sample analysis. It operates in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company was incorporated in 2012 and is headquartered in Boston, Massachusetts.
